Financhill
Sell
22

MPLN Quote, Financials, Valuation and Earnings

Last price:
$6.01
Seasonality move :
-30.28%
Day range:
$5.96 - $6.74
52-week range:
$4.80 - $69.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.10x
P/B ratio:
0.47x
Volume:
136.8K
Avg. volume:
83.3K
1-year change:
-90.65%
Market cap:
$97.4M
Revenue:
$961.5M
EPS (TTM):
-$94.90

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MPLN
MultiPlan
$233M -$2.37 -3.84% -25.95% --
DRIO
DarioHealth
$7.4M -$0.18 104.95% -60.98% --
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$2.6M -- -13% -- --
SPOK
Spok Holdings
$34.3M $0.24 4.56% 18.18% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MPLN
MultiPlan
$6.02 -- $97.4M -- $0.00 0% 0.10x
DRIO
DarioHealth
$0.80 -- $27.3M -- $0.00 0% 1.25x
FOXO
FOXO Technologies
$0.28 -- $4.9M -- $0.00 0% 2.10x
OTRK
Ontrak
$1.44 -- $6.1M -- $0.00 0% 0.50x
SPOK
Spok Holdings
$15.96 -- $323.5M 21.86x $0.31 7.83% 2.37x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MPLN
MultiPlan
95.61% 0.073 3661.33% 0.91x
DRIO
DarioHealth
33.03% 1.132 82.25% 1.27x
FOXO
FOXO Technologies
224.55% 16.543 1241.69% 0.06x
OTRK
Ontrak
40.88% 4.227 95.85% 0.98x
SPOK
Spok Holdings
-- 0.265 -- 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MPLN
MultiPlan
$169.7M $23.4M -27.36% -141.48% -146.15% $41.1M
DRIO
DarioHealth
$3.9M -$12M -49.97% -71.65% -162.06% -$7.4M
FOXO
FOXO Technologies
$655K -$1.1M -- -- -83.28% $576K
OTRK
Ontrak
$1.6M -$5.1M -149.3% -231.34% -198.72% -$1.4M
SPOK
Spok Holdings
$27.7M $5.3M 9.13% 9.13% 15.31% $10.3M

MultiPlan vs. Competitors

  • Which has Higher Returns MPLN or DRIO?

    DarioHealth has a net margin of -169.83% compared to MultiPlan's net margin of -166.11%. MultiPlan's return on equity of -141.48% beat DarioHealth's return on equity of -71.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    DRIO
    DarioHealth
    52.23% -$0.25 $87.4M
  • What do Analysts Say About MPLN or DRIO?

    MultiPlan has a consensus price target of --, signalling upside risk potential of 66.11%. On the other hand DarioHealth has an analysts' consensus of -- which suggests that it could grow by 337.5%. Given that DarioHealth has higher upside potential than MultiPlan, analysts believe DarioHealth is more attractive than MultiPlan.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 0 0
    DRIO
    DarioHealth
    3 0 0
  • Is MPLN or DRIO More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.468, suggesting its more volatile than the S&P 500 by 46.822%.

  • Which is a Better Dividend Stock MPLN or DRIO?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MultiPlan pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or DRIO?

    MultiPlan quarterly revenues are $230.5M, which are larger than DarioHealth quarterly revenues of $7.4M. MultiPlan's net income of -$391.5M is lower than DarioHealth's net income of -$12.3M. Notably, MultiPlan's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.10x versus 1.25x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.10x -- $230.5M -$391.5M
    DRIO
    DarioHealth
    1.25x -- $7.4M -$12.3M
  • Which has Higher Returns MPLN or FOXO?

    FOXO Technologies has a net margin of -169.83% compared to MultiPlan's net margin of -162.71%. MultiPlan's return on equity of -141.48% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    FOXO
    FOXO Technologies
    54.77% -$0.15 $14M
  • What do Analysts Say About MPLN or FOXO?

    MultiPlan has a consensus price target of --, signalling upside risk potential of 66.11%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that MultiPlan has higher upside potential than FOXO Technologies, analysts believe MultiPlan is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 0 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is MPLN or FOXO More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock MPLN or FOXO?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MultiPlan pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or FOXO?

    MultiPlan quarterly revenues are $230.5M, which are larger than FOXO Technologies quarterly revenues of $1.2M. MultiPlan's net income of -$391.5M is lower than FOXO Technologies's net income of -$1.9M. Notably, MultiPlan's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.10x versus 2.10x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.10x -- $230.5M -$391.5M
    FOXO
    FOXO Technologies
    2.10x -- $1.2M -$1.9M
  • Which has Higher Returns MPLN or OTRK?

    Ontrak has a net margin of -169.83% compared to MultiPlan's net margin of -217.21%. MultiPlan's return on equity of -141.48% beat Ontrak's return on equity of -231.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    OTRK
    Ontrak
    62.05% -$1.77 $19.4M
  • What do Analysts Say About MPLN or OTRK?

    MultiPlan has a consensus price target of --, signalling upside risk potential of 66.11%. On the other hand Ontrak has an analysts' consensus of -- which suggests that it could grow by 177.78%. Given that Ontrak has higher upside potential than MultiPlan, analysts believe Ontrak is more attractive than MultiPlan.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 0 0
    OTRK
    Ontrak
    0 0 0
  • Is MPLN or OTRK More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.569, suggesting its more volatile than the S&P 500 by 156.857%.

  • Which is a Better Dividend Stock MPLN or OTRK?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MultiPlan pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or OTRK?

    MultiPlan quarterly revenues are $230.5M, which are larger than Ontrak quarterly revenues of $2.6M. MultiPlan's net income of -$391.5M is lower than Ontrak's net income of -$5.6M. Notably, MultiPlan's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.10x versus 0.50x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.10x -- $230.5M -$391.5M
    OTRK
    Ontrak
    0.50x -- $2.6M -$5.6M
  • Which has Higher Returns MPLN or SPOK?

    Spok Holdings has a net margin of -169.83% compared to MultiPlan's net margin of 10.5%. MultiPlan's return on equity of -141.48% beat Spok Holdings's return on equity of 9.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    MPLN
    MultiPlan
    73.61% -$24.25 $4.7B
    SPOK
    Spok Holdings
    79.54% $0.18 $156.3M
  • What do Analysts Say About MPLN or SPOK?

    MultiPlan has a consensus price target of --, signalling upside risk potential of 66.11%. On the other hand Spok Holdings has an analysts' consensus of -- which suggests that it could fall by -6.02%. Given that MultiPlan has higher upside potential than Spok Holdings, analysts believe MultiPlan is more attractive than Spok Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    MPLN
    MultiPlan
    0 0 0
    SPOK
    Spok Holdings
    0 0 0
  • Is MPLN or SPOK More Risky?

    MultiPlan has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.334, suggesting its less volatile than the S&P 500 by 66.63%.

  • Which is a Better Dividend Stock MPLN or SPOK?

    MultiPlan has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.83% to investors and pays a quarterly dividend of $0.31 per share. MultiPlan pays -- of its earnings as a dividend. Spok Holdings pays out 163.68% of its earnings as a dividend.

  • Which has Better Financial Ratios MPLN or SPOK?

    MultiPlan quarterly revenues are $230.5M, which are larger than Spok Holdings quarterly revenues of $34.9M. MultiPlan's net income of -$391.5M is lower than Spok Holdings's net income of $3.7M. Notably, MultiPlan's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 21.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MultiPlan is 0.10x versus 2.37x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MPLN
    MultiPlan
    0.10x -- $230.5M -$391.5M
    SPOK
    Spok Holdings
    2.37x 21.86x $34.9M $3.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock